AI Labs Face Challenges Making Cross-Testing Mandatory for Safety

OpenAI and Anthropic came close to a formal agreement that would have let them test each other’s AI models for safety vulnerabilities. The deal reached the contracting stage before it quietly fell apart.

The collapse of this cross-testing agreement highlights a fundamental tension in AI development. Both companies recognize the value of external scrutiny, yet the practical barriers-competitive risk, intellectual property exposure, and legal liability-proved insurmountable in a voluntary framework. Microsoft shareholders should pay attention because the company holds a roughly 27% stake in OpenAI and booked a $3.2 billion gain on its Anthropic investment. When the two labs Microsoft is most exposed to can’t agree to check each other’s work, that risk lands squarely on Microsoft’s balance sheet.

The logic behind cross-testing is straightforward. Each AI lab has blind spots in its own safety evaluations. Internal teams become familiar with their model’s quirks and develop testing routines that reflect their assumptions about what matters. An external team brings fresh eyes and different priorities. They might probe for vulnerabilities the original developers didn’t anticipate or test scenarios that seemed unlikely from inside the building.

OpenAI and Anthropic are the two frontier labs that attract the most regulatory and public scrutiny. A mutual testing arrangement would have demonstrated industry leadership on safety while potentially surfacing real issues before deployment. Elon Musk floated a similar idea at the All-In Summit, and Mustafa Suleyman, who leads Microsoft’s AI efforts, called cross-testing “the smartest safety idea in months.”

The agreement got far enough that lawyers were involved, meaning both companies saw enough value to invest in formal contract language. Then it died. The reporting doesn’t specify why, but the structural obstacles aren’t hard to identify.

The failed OpenAI–Anthropic cross-testing agreement illustrates why voluntary AI safety cooperation is difficult: each lab would bear the costs of exposing proprietary weaknesses and documenting potential liabilities, while competitors could avoid those risks. A mandatory, regulator-supervised testing framework could make external validation more workable and create an opportunity for Microsoft to sell compliance-oriented AI services, even as it faces higher costs and delays through its exposure to both labs.

Giving a competitor privileged access to probe your AI model means handing them a detailed map of your capabilities, limitations, and failure modes. That’s information normally protected by trade secret law. A testing arrangement requires disclosing where your guardrails sit, which prompts bypass them, and which tasks the model handles poorly.

For a lab racing to maintain its technical lead, that disclosure carries immediate commercial cost. The safety benefit, meanwhile, is diffuse and uncertain. You might discover a vulnerability you wouldn’t have found on your own, or the external team might confirm what you already suspected. The asymmetry makes voluntary participation difficult to justify once lawyers score the downside.

Distillation poses another problem. In AI development, distillation is the practice of using a more capable model’s outputs to train a smaller, cheaper model that approximates its behavior. A company with query access to your model has the raw material needed for distillation. Even if the testing agreement includes contractual prohibitions, enforcement is tricky. How do you prove that a competitor’s next model was influenced by knowledge gained during testing?

These aren’t hypothetical concerns. Both OpenAI and Anthropic have commercial incentives to protect their technical advantages. OpenAI’s valuation depends partly on maintaining its position as the frontier lab with the broadest deployment. Anthropic positions itself as the safety-focused alternative, but it still competes for the same enterprise contracts. Neither company can afford to give the other a meaningful edge.

Elon Musk’s comment about liability cuts to the core issue. If a lab receives a documented external warning about a safety risk and ships the model anyway, it has created a written record of known risk. That changes the legal calculus entirely. Corporate counsel doesn’t read white papers-they read discovery documents and deposition transcripts. A formal safety warning from a respected external evaluator is exactly the kind of evidence that makes plaintiffs’ attorneys salivate.

This creates a perverse incentive. The party that adopts cross-testing first inherits the paper trail. The party that stays out avoids it. A voluntary regime punishes participants and rewards holdouts. That’s why Musk’s framing matters. He’s describing a structural instability, not just a coordination problem.

The only way to remove that asymmetry is to make cross-testing mandatory. If everyone has to do it, nobody gains a competitive advantage by opting out, and nobody carries unique liability for documented warnings. A rule imposed on all frontier labs levels the playing field while theoretically improving safety across the board.

The collapse of the deal is less evidence of weak safety commitments than of a broken incentive structure. If policymakers want meaningful external scrutiny, they must separate testing from direct competitor access, protect legitimate trade secrets, and ensure that participation does not create a unique liability penalty. For Microsoft, the key investment question is whether model assurance becomes an enforceable enterprise requirement rather than another voluntary promise.

Microsoft might be the best way to play a shift toward mandatory external validation. The company sells AI tools into banks, hospitals, and government agencies-exactly the kinds of regulated buyers that will demand externally validated models once a regulator requires it. Azure revenue crossed $100 billion annually, and Microsoft 365 Copilot passed 30 million paid seats, most of them inside organizations that already face strict compliance requirements.

A mandatory cross-testing regime would raise the fixed cost of shipping a frontier model. Scale players absorb fixed costs more easily than smaller labs can. Microsoft has the resources, the existing enterprise relationships, and the cloud infrastructure to benefit from a regulatory framework that requires third-party model assurance.

There’s also a subtle point about certification dynamics. If two dominant labs end up certifying each other, that arrangement could become a mutual validation system that raises barriers to entry without materially improving safety. Regulators have historically accepted industry-led certification frameworks in other sectors, often because they lack the technical capacity to design alternatives. Microsoft, with stakes in both OpenAI and Anthropic, would be well-positioned if that dynamic plays out.

The company’s commercial remaining performance obligations stand at $678 billion, up 84%. That’s a book of business that already prices in enterprise trust. If model assurance becomes a paid requirement, Microsoft has the relationships and technical infrastructure to deliver it at scale.

The bull case is that model validation becomes a mandatory enterprise requirement, and Microsoft is the vendor best positioned to sell it. The company already integrates AI into products that serve regulated industries. Adding external validation as a compliance feature fits naturally into the existing sales motion. Buyers that already trust Microsoft for security and compliance would likely trust the company to deliver validated AI models as well.

The bear case is that Microsoft carries frontier-lab exposure it doesn’t fully control into a governance environment that remains unsettled. The company’s valuation already reflects significant AI optimism. Microsoft stock trades at $500.59, up 4.17% year to date but down 0.88% over one year. That sideways movement suggests the market has largely priced in the AI narrative. The deciding variable is whether external model validation becomes something enterprise buyers must purchase or stays a press release item.

A recent CNBC piece noted a rare Microsoft bear warming to the shares. That kind of sentiment shift often precedes a fundamental answer, one way or the other. If regulators mandate cross-testing, Microsoft benefits. If the voluntary approach continues to fail without replacement, the risk stays on Microsoft’s balance sheet through its OpenAI and Anthropic stakes.

The structural problems with voluntary cross-testing won’t resolve themselves. Competitive disclosure, distillation risk, and liability asymmetry are inherent features of the current AI development environment. As long as frontier labs compete for the same customers and investor capital, they’ll face pressure to protect proprietary information and avoid creating legal records that could be used against them.

The collapse of the OpenAI-Anthropic deal demonstrates that even companies with stated commitments to safety can’t overcome these barriers in a voluntary framework. Both labs employ respected safety researchers. Both have published extensive documentation about their approach to alignment and testing. Neither lacks awareness of the risks. Yet when the deal reached the formal stage, it fell apart.

That failure suggests the problem isn’t bad faith or insufficient commitment. It’s that the incentive structure makes voluntary cross-testing irrational for individual participants. Each lab faces immediate costs and deferred benefits, while competitors that opt out avoid the costs without sacrificing the benefits of industrywide safety improvements.

A mandatory testing regime would need to address several design questions. Who conducts the tests-rival labs, independent third parties, or government agencies? What gets tested-pre-deployment models, deployed systems, or both? How are results shared-publicly, with regulators, or kept confidential? Who bears liability for models that pass testing but later cause harm?

The most likely path involves a hybrid approach. Frontier labs would be required to submit models for external evaluation before deployment. Testing could be conducted by a rotating panel of other labs, overseen by a regulatory body that sets standards and reviews results. Findings would be shared with regulators, who would have authority to block deployment if critical risks are identified. Public disclosure would be limited to protect proprietary information while still providing transparency about the testing process.

This approach preserves some competitive confidentiality while removing the voluntary coordination problem. Labs that discover vulnerabilities during cross-testing would report them to regulators rather than directly to competitors. That intermediary layer reduces the risk of commercial exploitation while still surfacing safety issues before deployment.

How quickly might mandatory cross-testing arrive? The EU AI Act already includes provisions for high-risk AI systems that could be interpreted to require external validation. The US regulatory environment remains less defined, but the Biden administration’s executive order on AI safety signaled increased government attention. If a high-profile AI incident occurs-a model that causes measurable harm in a way that internal testing should have caught-regulatory momentum could accelerate quickly.

The voluntary deal between OpenAI and Anthropic collapsed sometime in 2025, according to the reporting. That timeline matters because it suggests the labs tried to get ahead of regulation and couldn’t make the economics work. If voluntary coordination fails, regulatory mandates become more likely. Policymakers tend to intervene when industry self-governance proves inadequate.

Microsoft shareholders should watch for signals that mandatory testing is moving from theoretical to actual. Those signals include: specific legislative proposals that define testing requirements, regulatory agencies hiring technical staff with AI expertise, industry groups proposing standardized testing protocols, and enterprise buyers beginning to demand external validation in procurement contracts.

The collapsed cross-testing deal exposes a gap between stated commitments to safety and the practical willingness to accept costs and risks. Both OpenAI and Anthropic have emphasized safety in their public communications. Both employ researchers focused on alignment and catastrophic risk. Yet when presented with a concrete mechanism for external scrutiny, the deal died.

That gap matters because it suggests voluntary safety measures will remain limited by competitive pressures. Labs will do what they can within the constraints of protecting proprietary information and avoiding liability exposure. But meaningful external validation-the kind that might actually surface critical vulnerabilities-requires giving up advantages that labs aren’t willing to surrender voluntarily.

Mandatory cross-testing won’t solve every AI safety problem. Models might pass external tests and still cause harm in deployment. Testing standards might lag behind capability improvements. Labs might find ways to game the testing process. But a mandatory framework removes the voluntary coordination problem and creates a baseline expectation that frontier models face external scrutiny before deployment.

For Microsoft, the shift from voluntary to mandatory testing represents both opportunity and exposure. Opportunity because the company is well-positioned to sell validated AI into enterprise buyers that will pay for compliance. Exposure because Microsoft carries significant stake in two frontier labs that will face increased regulatory costs and potential deployment delays if mandatory testing arrives.

The market hasn’t fully priced in which scenario plays out. Microsoft’s sideways stock performance over the past year suggests uncertainty about whether AI governance will tighten or stay loose. The collapsed cross-testing deal tips the scales slightly toward tighter regulation, because it demonstrates that voluntary approaches face insurmountable barriers. That makes Microsoft’s dual exposure to OpenAI and Anthropic more complex and potentially more valuable, depending on how quickly mandatory testing becomes enterprise reality.